Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cadvog M 500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Caddes Life Sciences

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Cadvog M 500mg/0.3mg Tablet SR

Diabeva 500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose control. Diabeva should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are vital in diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, flatulence, abdominal discomfort, diarrhea, and skin reactions. These are usually transient and self-limiting; however, persistent or concerning side effects warrant medical attention. Your doctor can provide strategies to manage or treat any bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women must consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Cadvog M 500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Cadvog M 500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cadvog M 500mg/0.3mg Tablet SR whole; do not crush, chew, or divide the tablet. Administer this medication with food.

Common Side effects of Cadvog M 500mg/0.3mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Cadvog M 500mg/0.3mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Cadvog M 500mg/0.3mg Extended-Release Tablet should be administered with a meal.

How Cadvog M 500mg/0.3mg Tablet SR works:

Cadvog M 500mg/0.3mg extended-release tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Cadvog M 500mg/0.3mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Cadvog M tablets (500mg/0.3mg) might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Cadvog M 500mg/0.3mg Tablet SR while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

The extended-release Cadvog M 500mg/0.3mg tablet typically does not impair driving ability. Nevertheless, individuals using this medication concurrently with other diabetes treatments, including sulfonylureas, insulin, or repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Cadvog M 500mg/0.3mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Cadvog M 500mg/0.3mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Cadvog M 500mg/0.3mg sustained-release tablets to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Cadvog M 500mg/0.3mg Tablet SR :

Should you forget to take a Cadvog M 500mg/0.3mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cadvog M 500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management
Cadvog M 500mg/0.3mg Tabl...
73
MRP 85
14% off